Search research articles
Contact Us
Filters
Showing results (471-480 of 610) with videos related to
Page
of 61
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
June 21, 2022
SHANK3 deficiency leads to myelin defects in the central and peripheral nervous system
Mariagiovanna Malara, Anne-Kathrin Lutz, Berra Incearap, et al.
Cancers
|
September 10, 2021
Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study
Evangelos Terpos, Maria Gavriatopoulou, Despina Fotiou, et al.
British Journal of Haematology
|
April 6, 2007
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
Marie-Christine Kyrtsonis, Theodoros P Vassilakopoulos, Nicoletta Kafasi, et al.
Science Translational Medicine
|
December 8, 2017
BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions
Maryam K Fard, Franziska van der Meer, Paula Sánchez, et al.
Clinical Lung Cancer
|
October 25, 2023
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer
Aakash Desai, Caleb J Smith, Yash Ashara, et al.
Cancer Treatment and Research Communications
|
August 2, 2023
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report
Aakash Desai, Sagar Rakshit, Radhika Bansal, et al.
Frontiers in Robotics and AI
|
October 4, 2021
The i-Walk Lightweight Assistive Rollator: First Evaluation Study
George Moustris, Nikolaos Kardaris, Antigoni Tsiami, et al.
JTO Clinical and Research Reports
|
November 24, 2025
Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLC
Arthi Sridhar, Aditi Singh, Scott Hansen, et al.
Advances in Hematology
|
November 30, 2013
Prognostic significance of serum free light chains in chronic lymphocytic leukemia
Katerina Sarris, Dimitrios Maltezas, Efstathios Koulieris, et al.
Hematological Oncology
|
September 11, 2012
Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents
Dimitrios Maltezas, Meletios A Dimopoulos, Irene Katodritou, et al.
Page
of 61
Search research articles
Search
Showing results (471-480 of 610) with videos related to
Sort By:
Page
of 61
Cellular and Molecular Life Sciences : CMLS
|
June 21, 2022
SHANK3 deficiency leads to myelin defects in the central and peripheral nervous system
Mariagiovanna Malara, Anne-Kathrin Lutz, Berra Incearap, et al.
Cancers
|
September 10, 2021
Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study
Evangelos Terpos, Maria Gavriatopoulou, Despina Fotiou, et al.
British Journal of Haematology
|
April 6, 2007
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
Marie-Christine Kyrtsonis, Theodoros P Vassilakopoulos, Nicoletta Kafasi, et al.
Science Translational Medicine
|
December 8, 2017
BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions
Maryam K Fard, Franziska van der Meer, Paula Sánchez, et al.
Clinical Lung Cancer
|
October 25, 2023
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer
Aakash Desai, Caleb J Smith, Yash Ashara, et al.
Cancer Treatment and Research Communications
|
August 2, 2023
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report
Aakash Desai, Sagar Rakshit, Radhika Bansal, et al.
Frontiers in Robotics and AI
|
October 4, 2021
The i-Walk Lightweight Assistive Rollator: First Evaluation Study
George Moustris, Nikolaos Kardaris, Antigoni Tsiami, et al.
JTO Clinical and Research Reports
|
November 24, 2025
Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLC
Arthi Sridhar, Aditi Singh, Scott Hansen, et al.
Advances in Hematology
|
November 30, 2013
Prognostic significance of serum free light chains in chronic lymphocytic leukemia
Katerina Sarris, Dimitrios Maltezas, Efstathios Koulieris, et al.
Hematological Oncology
|
September 11, 2012
Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents
Dimitrios Maltezas, Meletios A Dimopoulos, Irene Katodritou, et al.
Page
of 61